Active, not recruitingPhase 3NCT05929079
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
Studying Carnevale syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eli Lilly and Company
- Principal Investigator
- Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company
- Intervention
- Retatrutide(drug)
- Enrollment
- 1000 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (30)
- Pinnacle Research Group, LLC, Anniston, Alabama, United States
- Cullman Clinical Trials, Cullman, Alabama, United States
- Preferred Research Partners, Little Rock, Arkansas, United States
- Core Healthcare Group, Cerritos, California, United States
- Velocity Clinical Research, Westlake, Los Angeles, California, United States
- Valley Clinical Trials, Inc., Northridge, California, United States
- Diablo Clinical Research, Inc., Walnut Creek, California, United States
- Chase Medical Research, LLC, Waterbury, Connecticut, United States
- Excel Medical Clinical Trials, Boca Raton, Florida, United States
- Teradan Clinical Trials, LLC, Brandon, Florida, United States
- Fleming Island Center for Clinical Research, Fleming Island, Florida, United States
- Therafirst Medical Center, Fort Lauderdale, Florida, United States
- Clinical Site Partners LLC, dba Flourish Research, Miami, Florida, United States
- Quantum Clinical Trials, Miami Beach, Florida, United States
- Renstar Medical Research, Ocala, Florida, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05929079 on ClinicalTrials.govOther trials for Carnevale syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07434050A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure TherapyHangzhou Sciwind Biosciences Co., Ltd.
- ENROLLING BY INVITATIONNCT07476313Validation and Usability Study of the SleepView+ Home Sleep Testing System for the Evaluation of Moderate to Severe Obstructive Sleep Apnea.Beacon Biosignals
- RECRUITINGPHASE3NCT07226765Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) TherapyAmgen
- RECRUITINGNANCT07464262Telemonitoring With CPAP in Severe Obstructive Sleep Apnea in Primary Health CareFederal University of São Paulo
- RECRUITINGNCT06971874The Outcome of Chronic Kidney Disease Patients With Obstructive Sleep Apnea SyndromeNanfang Hospital, Southern Medical University
- RECRUITINGNANCT06381115App-Based Optimization of Long-Term CPAP Adherence and Quality of LifeMayo Clinic
- RECRUITINGNCT07060079The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory DiseaseUniversity College, London
- RECRUITINGNANCT06715228Efficacy of Shitali Respiratory Rehabilitation Program in Obstructive Sleep ApneaCairo University